A Chinese oral contraceptive pill that harms Kenyan women is no longer permitted for use or distribution in the nation, according to the Pharmacy and Poisons Board.
The product is substandard and false (SF), and it poses a serious risk to the public’s health and safety, according to a portion of the board’s statement.
PPB claims that in order to confirm and examine if the oral contraceptive “Sophia” is available on the Kenyan market, it has started a quick response and increased surveillance.
The medication is simple to get online, from “herbal clinics,” as well as from dishonest dealers who ship orders across the nation.
The tablets are appealing to women who are interested in family planning because of their relative price (approximately Sh200 per tablet) and the fact that they are only used once each month.
The substance is hazardous and has a negative influence on the consumer, according to samples the Ministry of Health collected and evaluated.
Levonorgestrel and quinestrol, the hormones that are the main components of conventional contraceptive pills, were found to be excessively high in the pill during a previous investigation at the National Quality Control Laboratory (NQCL) that resulted in the drug’s prohibition.
The drug causes severe damage to the reproductive system of women.
